{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:47:41Z","timestamp":1773956861569,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ygyno.2024.08.016","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:22:50Z","timestamp":1724718170000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma"],"prefix":"10.1016","volume":"190","author":[{"given":"Mayumi Kobayashi","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Asami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Hiranuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouya","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.08.016_bb0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2023.09.011","article-title":"Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer","volume":"178","author":"Kobayashi-Kato","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.07.090","article-title":"Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment","volume":"143","author":"Talhouk","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2019.06.012","article-title":"Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: towards early personalized patient management","volume":"154","author":"Abdulfatah","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ijgc-2022-004039","article-title":"Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program","volume":"33","author":"Consortium RR","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0030","series-title":"WHO Classification of Tumours Editorial Board. Female Genital Tumors","author":"Cancer IAfRo","year":"2020"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0035","series-title":"The 2020 World Health Organization Tumor Classification","author":"WC","year":"2016"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0040","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41416-023-02203-3","article-title":"Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer","volume":"128","author":"Asami","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2019.10.022","article-title":"Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients","volume":"156","author":"Hirose","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0050","doi-asserted-by":"crossref","first-page":"19261","DOI":"10.1038\/s41598-021-98527-2","article-title":"TP53 mutants and non-HPV16\/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer","volume":"11","author":"Kuno","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0055","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1038\/s41598-021-90139-0","article-title":"Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy","volume":"11","author":"Murakami","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0060","first-page":"13","article-title":"Comparative analysis of genetic alterations, HPV-status, and PD-L1 expression in neuroendocrine carcinomas of the cervix","author":"Takayanagi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc.2015.12","article-title":"A panoply of errors: polymerase proofreading domain mutations in cancer","volume":"16","author":"Rayner","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/annonc\/mdw542","article-title":"Practical guidance for mismatch repair-deficiency testing in endometrial cancer","volume":"28","author":"Stelloo","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5858\/arpa.2021-0632-CP","article-title":"Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: guideline from the College of American Pathologists in collaboration with the Association for Molecular Pathology and Fight Colorectal Cancer","volume":"146","author":"Bartley","year":"2022","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0105","series-title":"Categorical Data Analysis","author":"Agresti","year":"1990"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0115","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e9","article-title":"Baseline risk of recurrence in stage I-II endometrial carcinoma","volume":"29","author":"Sasada","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/modpathol.2008.97","article-title":"Histologic and immunohistochemical decision-making in endometrial adenocarcinoma","volume":"21","author":"Lomo","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1699-0463.1995.tb01399.x","article-title":"Interobserver agreement for tumour type, grade of differentiation and stage in endometrial carcinomas","volume":"103","author":"Nedergaard","year":"1995","journal-title":"APMIS"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/IGC.0b013e31821454f1","article-title":"Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens","volume":"21","author":"Guan","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0140","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e31828c63ed","article-title":"Histotype-genotype correlation in 36 high-grade endometrial carcinomas","volume":"37","author":"Hoang","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0145","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0155","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2024.08.016_bb0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ygyno.2014.02.012","article-title":"High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma","volume":"133","author":"Stelloo","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.016_bb0175","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ygyno.2018.04.005","article-title":"Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy\/curettage or hysterectomy specimens","volume":"149","author":"Chapel","year":"2018","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T02:06:20Z","timestamp":1730945180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824010849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S0090825824010849"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.08.016","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}